Health ministry to delay evaluation plan for 1,880 OTCs

Published: 2010-08-18 06:58:00

Updated: 2010-08-18 06:58:00

The Ministry of Health and Welfare Affairs said on August 13 that it will evaluate he economic effectiveness of insurance-covered 1,880 over-the-counter drugs until the second half of next year.

Of the 1,880 medicines, famous brands (e.g., Urusa, Tylenol, Aspirin, Gelfos, Ginexin, Tanamin and ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK